Prostaglandin synthetase inhibition and formation of lipoxygenase products in immunologically challenged normal human lung parenchyma

Eicosanoids. 1988;1(2):73-7.

Abstract

Normal human lung parenchyma, passively sensitized with an hyperimmune serum, releases eicosanoids from the cyclo-oxygenase pathway and from different lipoxygenases (5-, 12-, 15-HETE) upon anti-IgE challenge. Prostaglandin D2 represents almost 50% of the total arachidonate metabolites whereas, among sulphidopeptide leukotrienes, LTE4 is the one present in larger amounts. Pretreatment of the passively sensitized tissue with indomethacin (1.5 X 10(-5) M) inhibits cyclo-oxygenase by more than 90% without a concomitant shift of arachidonate metabolism towards leukotriene formation.

MeSH terms

  • Biological Assay
  • Chromatography, High Pressure Liquid
  • Cyclooxygenase Inhibitors*
  • Humans
  • Immune Sera
  • Immunoenzyme Techniques
  • Indomethacin / pharmacology
  • Leukotrienes / metabolism
  • Lipoxygenase / metabolism*
  • Lung / enzymology
  • Lung / immunology
  • Lung / metabolism*
  • Prostaglandin D2 / analysis
  • Reference Values
  • SRS-A / analysis

Substances

  • Cyclooxygenase Inhibitors
  • Immune Sera
  • Leukotrienes
  • SRS-A
  • Lipoxygenase
  • Prostaglandin D2
  • Indomethacin